• Applied Magix’s product selection for consumers includes The MagixDrive Wireless CarPlay Adapter, The HomeKit Secure Video Camera with iCloud Storage, The Multipurpose Sensor with Alarm, The Environment and Motion Sensor, and The Window and Door Contact Sensor
• The next phase of the ad campaign will ramp up the frequency of the ads and expand upon a higher interest profile of viewers
• Smart home market size was valued at $98.24 billion in 2020 and is expected to grow at a CAGR of 23.59% from 2021 to 2028

Technology company SPYR (OTCQB: SPYR), dba SPYR Technologies, announced the expansion of a comprehensive marketing campaign for its subsidiary Applied Magix Inc. to additional markets, further broadening viewership for the brand (https://ibn.fm/UHVRD). SPYR operates through its Applied Magix Inc. subsidiary, developing and reselling Apple(R)-ecosystem-compatible products emphasizing a growing, multibillion-dollar Internet of Things (“IoT”) Smart Home and Connected Car markets. Consisting of both 30- and 60-second commercials, the dynamic TV ad campaign for MagixDrive, Applied Magix’s wireless CarPlay device, is being handled by TVA Media Group (“TVA”) and BB3 Advertising. TVA began this dynamic TV ad campaign by placing “test airings” of the commercials on different channels and timeslots during the last week of December. TVA estimates that more than one million viewers saw these ads based on the channels and time slots they were given. These initial airings serve as a test to determine specific interest from different demographic groups, and after the data was analyzed, a more strategic broadcast strategy was created. The campaign for MagixDrive is moving toward the next phase of development, increasing the frequency of the ads and continuing to focus on the best fit demographic profile of what the company refers to as a “perfect customer.” The plan is to expand upon this and fit a higher interest profile with the aired ads. “We continue to enjoy working with such talented and experienced organizations like TVA and BB3,” Applied Magix CEO, Dr. Harald Zink, voiced his enthusiasm about the campaign. “This has turned out to be an extremely valuable partnership. With their help, we have created an exciting advertising campaign that we expect to be a success.” Applied Magix offers multiple product lines to each of its target markets. The company finds white label products, applies its branding, updates and improves the software, and sells the improved product to consumers. The company is also developing its own proprietary line of smart home and car-related products, including Apple(R)-compatible home cameras, sensors, alarms, and additional compatible smart car products in the iOS infrastructure. Current products being sold to consumers by Applied Magix include:

• The MagixDrive Wireless CarPlay Adapter (https://appliedmagix.com/shop/carplay/magixdrive-wireless-carplay/)
• The HomeKit Secure Video Camera with iCloud Storage (https://appliedmagix.com/shop/cameras/onvis-c3-camera/)
• The Multipurpose Sensor with Alarm (https://appliedmagix.com/shop/sensors/onvis-cs1-smart-sensor-alarm/)
• The Environment and Motion Sensor (https://appliedmagix.com/shop/sensors/onvis-sms1-homekit-motion-sensor/)
• The Window and Door Contact Sensor (https://appliedmagix.com/shop/sensors/onvis-door-window-contact-sensor-ct2/)

These and other products can be purchased at their online shop (https://appliedmagix.com/shop/). The smart home market is growing exponentially, providing multiple opportunities for companies such as SPYR. According to Verified Market Research, the market was valued at $98.24 billion in 2020 and is expected to grow at a CAGR of 23.59% from 2021 to 2028 – resulting in an estimated revenue of $495.15 billion by the end of the forecast period (https://ibn.fm/047f1). This growth can be attributed to the increasing number of homeowners turning to smart devices like video doorbells, voice-assisted technological solutions, and surveillance systems. For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

• NA legal cannabis market size projected to grow at CAGR of 16.6% from 2022 to 2028
• More than 3,500 peer-reviewed scientific papers studying cannabis were published in 2020 alone
• SGMD reaches key objectives, seeing key growth in 2021

After a year of impressive progress and growth, Sugarmade (OTC: SGMD) has established an enviable position in the legal cannabis market, a sector that is expected to see an estimated 16.6% growth in the coming years (https://ibn.fm/ELp2X). “The North America legal cannabis market size was valued at USD 12.4 billion in 2021 and is projected to grow at a compound annual growth rate (‘CAGR’) of 16.6% from 2022 to 2028,” the most recent Grand View Research report stated. “Growing legalization and the rising awareness about the health benefits of the consumption of cannabis are the major factors driving the market growth. “In addition, the rising need for remedies for pain management among the patient population and an increasing number of patients suffering from chronic pain and other conditions in the region are also anticipated to fuel the market growth over the forecast period,” the report noted. “The rising utilization of cannabis for medical as well as nonmedical purposes is increasing in the North American region, thereby paving way for the growth of the market.” The increased awareness of cannabis benefits has come from growing cannabis research. In fact, cannabis research is in full swing, according to the “Seattle Times,” which reported that “after a dormant period, the U.S. Drug Enforcement Administration has moved on authorizing federally authorized marijuana manufacturers for research” (https://ibn.fm/Fjmmc). “Before 1999, there were fewer than 5,000 published cannabis studies in total, but with cannabis reform, over 3,500 peer-reviewed scientific papers were published in 2020 alone,” the article continued. “This critical work helps to destigmatize cannabis and reinforces the potential medical benefits of cannabis. Plus, understanding cannabinoids can lead to more efficient products.” At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a “landmark year” for the company, telling shareholders that in 2021 SGMD would “continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins. “We believe that we will also be better able to make use of 280e tax deductions related to production once we have a more vertical structure in place,” he stated (https://ibn.fm/2MDhW). “With our vertical vision coming together, our advantageous brand development positioning, and an increasingly promising macro context, we are very excited about the year in front of us.” The strategy for 2021 appears to have paid off as Sugarmade’s Nug Avenues hub in the Los Angeles metro area has grown dramatically since opening in March 2021 (https://ibn.fm/phNrt). In addition, the company is making significant progress on opening a second Nug Avenue location and has implemented new cannabis delivery technology to establish a competitive advantage in its core delivery zone. Finally, in 2021 the company moved closer to its goal of first planting at the large 640-acre outdoor cultivation site associated with its recently acquired Lemon Glow subsidiary. Sugarmade has set its eyes on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while also developing its in-house cannabis production capacity to verticalize operations in the space. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• Six LiDAR companies have gone public since 2020, raising $3.6+ billion as investors look for exposure to autonomous vehicles market
• Cepton is merging with Growth Capital Acquisition Corp GCAC in the coming weeks in a deal valuing Cepton at $1.55 billion, with $231 million in pro forma cash on its balance sheet
• Cepton has worked with the world’s biggest automotive OEMs, including General Motors and Ford, and garnered a $50 million investment for Japan’s Koito Manufacturing

As the race to fully autonomous vehicles (“AVs”) heats up, one particularly important pocket of the AV and advanced driver assistance systems (“ADAS”) markets is gaining momentum right along with it: LiDAR. LiDAR (short for “light detection and ranging”), developed for space applications and hyped for its potential in automotive applications, is moving beyond speculation and into revenue-generating reality. Investors are on board, with six LiDAR companies coming to market via special purpose acquisition companies (“SPACs”) since 2020, raising over $3.6 billion in the process, and another, Cepton, Inc.,  is dialed-in to go public on or about February 10th through a merger with the Growth Capital Acquisition (NASDAQ: GCAC) SPAC. LiDAR technology uses infrared laser beams to generate a three-dimensional map of the road and surrounding environment, serving, in a manner of speaking, as the eyes of an AV or ADAS. LiDAR is remarkably adept at detecting objects and measuring their distance from a vehicle with incredible precision and speed, even in bad weather and low light conditions. It cannot, however, tell the difference in colors or a rock from a human, which makes it an ideal candidate to work in adjunct with technology such as high-definition cameras, which can provide details on objects. While viewed by many as the future of AVs, LiDAR has faced numerous challenges, including high cost along with integration issues that are commonplace during introduction of any disruptive technology. Cepton was purposely assembled in 2016, developing and patenting its Micro Motion Technology (MMT(R)) LiDAR platform as a new, reliable, scalable, and cost-effective solutions that deliver long-range, high-resolution 3D perception for a range of markets (auto, smart cities, industrial, etc.), with the initial thrust on ADAS, the most robust market today. Unlike most peers that use rotating microscopic mirrors to bounce and measure laser beams, known as MEMS (micro-electro-mechanical systems), Cepton uses quartz-crystal-like materials, which provides better performance and lower power usage at a better price point. Cepton has also engineered its LiDAR system to work in different installations, including behind windshields, an auto industry first that gives Cepton a competitive advantage. In November, Cepton was named a CES(R) 2022 Innovation Awards Honoree in the Vehicle Intelligence & Transportation category for its Nova lidar, a miniature, wide field of view lidar sensor for near-range applications. The Cepton technology team has captured the attention of upper echelon companies and upstarts alike. Management says it is in negotiations with all the top 10 biggest original equipment manufacturers (“OEMs”) in the world, as well as four new electric vehicle OEMs. While some of this information remains closely guarded, Cepton has provided some valuable insight on its direction, including deals with Koito Manufacturing, General Motors (NYSE: GM), and Ford (NYSE: F). Tokyo-based Koito, a Tier 1 automotive lighting manufacturer, has licensed the Cepton technology on a non-exclusive basis. Furthermore, Koito made a $50 million investment in the company as part of a PIPE (private investment in a public entity) in connection with the upcoming SPAC merger. On a valuation level, GCAC has $172.5 million in cash and $58.5 million raised through the PIPE giving it $231 million in pro forma cash on the books. The company has a pro forma valuation of $1.55 billion, equivalent to 1.8x estimated 2025 revenue of $861 million. The Koito relationship resulted in Cepton securing the largest ADAS LiDAR production award (based on # of vehicle models) today through a new contract with GM. In fact, the three companies collaborated on development of a special type of glass used by Cepton sensors that are entering the GM ecosystem. With an initial term running from 2023 through 2027, all GM vehicles equipped with the automakers’ Ultra Cruise ADAS – expected to be up to nine different platforms of several models each – will exclusively use Cepton LiDAR sensors. Ultra Cruise is the next generation of GM ADAS, designed to ultimately work on every paved road in North America. Today, LiDAR is used in extremely limited fashion and only on ultra-high-end vehicles in select parts of the world. The agreement with GM positions Cepton as the first company to bring LiDAR sensors to production markets. Introduction to the mass markets is what will help drive Cepton’s production costs down from around $1,000 to down near $500 in the coming years, which will make the option even more affordable, subsequently driving greater adoption until the tech is mainstream. The working relationship with Ford has been in place almost since Cepton’s inception nearly six years ago. Ford is working with Cepton on different projects, including advanced ADAS features and on its some of Ford’s smart city projects, where Cepton LiDAR technology is already deployed. As the company has said, it is first addressing the rapidly emerging LiDAR for ADAS markets, but it has grander plans in the long run to address an array of applications. For more information, visit the company’s website at www.GCACorp.com NOTE TO INVESTORS: The latest news and updates relating to GCAC are available in the company’s newsroom at https://ibn.fm/GCAC

• Psychedelics pose potential as effective treatments for mental-health issues such as depression, anxiety, and substance abuse
• Well+Good says psychedelics “poised to change the course of mental health treatment”
• Cybin working to combine novel psychedelic molecules with controllable drug-delivery systems through proprietary deuterated process

A USA Today article is touting psychedelics as the next big thing in mental health treatment (https://ibn.fm/3ZGGE). This forecast aligns perfectly with what Cybin (NEO: CYBN) (NYSE American: CYBN) has been working toward since the company started: a strategic psychedelics to therapeutics model that will transform the mental health space. “If you haven’t heard about psychedelics being used as a treatment for mental health disorders, this year may change that,” the article stated. “While this type of treatment won’t be accessible to everyone in 2022 (and will likely take a while to become widespread), experts say you should expect to hear much more about this emerging wellness trend this year and beyond. “‘For a long time, psychedelics have been sort of frowned upon,’ says Amy Morin, psychotherapist and editor-in-chief at VeryWell Mind. ‘We thought they were more recreational drugs, but with a closer look, we’ve seen they can actually be really good treatments for things like depression, anxiety, even substance abuse issues.’” The article noted that Dr. Matthew W. Johnson, a professor of psychiatry and behavioral sciences at Johns Hopkins and acting director of the Johns Hopkins Center of Psychedelics and Consciousness Research, has seen a gradual increase in interest around psychedelics since he began focusing on them in 2004, but he said interest now is increasing dramatically; he thinks that interest will only increase moving forward. “In their 2022 wellness trend forecast, Well+Good dubbed psychedelics as being ‘poised to change the course of mental health treatment,’” the article stated. “Institutions are also getting ready by opening up specialized centers to study these drugs in a mental health capacity.” This dramatic increase bodes well for one of the leaders in the psychedelic space. On a mission to revolutionize mental health care, Cybin has developed key relationships with a network of world-class partners and internationally recognized scientists as it focuses on creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is working on turning its psychedelics to therapeutics vision into reality by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. At the core of this transformative work is Cybin’s efforts to combine novel psychedelic molecules with controllable drug-delivery systems through its proprietary deuterated process. In doing so, the company is creating patent-protected, commercially scalable drug candidates and establishing itself as a strong player in an industry projected to see significant growth. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts
• The company recently announced it has secured full licensing for manufacturing both medical and adult use cannabis products in Michigan, one of its key markets
• Red White & Bloom has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the state
• In Florida, Red White & Bloom settled a CAD$5.1 million debt at a favorable conversion price, granting the company an accounting gain of approximately CAD$2.3 million

As Michigan enters into its third year under legislation allowing the legal sale of adult “recreational use” cannabis, multi-state cannabis operator Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is celebrating corporate developments that include full licensing for manufacturing both medical and adult use cannabis products in the state. “We will be expanding the wildly popular Platinum Vape brand to include gummies and chocolates to capitalize on the existing brand equity we command in Michigan,” CEO and Chairman Brad Rogers stated in a Jan. 18 announcement (https://ibn.fm/kb0Ox). Red White & Bloom Brands, also known simply as RWB, received adult recreational use prequalification status for manufacture in Michigan in September, allowing it to begin marketing itself to the state’s approximately 10 million residents. The company has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in Warren, Mich., which is part of RWB’s strategic planned acquisition of 18 Michigan dispensaries, four cultivation facilities and other significant real estate announced in September (https://ibn.fm/gdxMJ). Eight of the dispensaries are already open with the remaining 10 in process, a January High Times article reports (https://ibn.fm/sND8F). “This Warren facility allows us to centralize distribution for our ‘house of premium brands’ in Michigan and finally report all of our Platinum Vape(TM) wholesale sales on a much less confusing and straightforward basis,” Rogers stated. “The facility provides the production capacity to expand sales of our award-winning brands from the 250+ Michigan dispensaries that carry them to the state’s 400+ dispensaries.” Platinum Vape, also referred to as PV by the company, recorded a 93 percent YOY increase in revenues as of the close of the company’s Q3 period, gaining it recognition as a top-selling brand in the state by LeafLink’s marketplace analysis (https://ibn.fm/LLC4c). Michigan’s cannabis sales were expected to approach $2 billion last year with a run-rate that falls behind only California and Colorado. RWB’s operations in California have granted its gummies, chocolates and premium cannabis flower popularity and the developments in Michigan will expand those products through Platinum Vape beyond California for the first time. RWB also operates in Florida, Illinois, Massachusetts and Arizona. Its Florida operations have progressed rapidly in recent months, where the installation of 30 grow pods at the company’s 45,000-square-foot Apopka cultivation site heralded the beginning of Phase 2 expansion for the company there (https://ibn.fm/cECpn). In addition, Red White & Bloom announced Dec. 30 that it had refinanced the principal amount of a debt established in connection with RWB Florida LLC’s acquisition of all of the issued and outstanding shares of Acreage Florida, Inc. At the same time, the company settled a CAD$5.1 million (US$4.0 million) debt at a favorable conversion price, granting the company an accounting gain of approximately CAD$2.3 million (US$1.8 million) (https://ibn.fm/LUIdJ) and helping RWB to better position itself for growth in the coming year. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029
• InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids
• It is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth

It is projected that by 2025, the global cannabis market will be valued at around $146 billion, up from just $20.47 billion in 2020. This sector is experiencing tremendous growth, particularly considering that there are over one hundred known cannabinoids, including rare ones that are quickly taking over and will soon dominate the cannabis market (https://ibn.fm/2NLFN). The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health, and wellness sectors. However, one that stands above the rest is the pharmaceuticals sector. It is growing at a rapid pace and is projected to be valued at $50 billion by 2029. An enterprise that is helping to define rare cannabinoids in the pharmaceutical sector is InMed Pharmaceuticals (NASDAQ: INM). This enterprise is laying down the foundation in the manufacturing and clinical development of rare cannabinoids. It is a trailblazer, a pioneer defining the value of rare cannabinoids in this sector and just how integral they are in pushing the pharmaceutical industry forward. InMed’s most advanced compound, INB-755, has already proven helpful in treating epidermolysis bullosa, a severe genetic disorder. The compound has undergone Phase 1 clinical trials with impressive results, and global Phase 2 clinical trials are underway. InMed is also working on its INM-008 compound for the treatment of glaucoma and is currently evaluating different formulations to deliver ocular cannabinoids into the eye. InMed studies were also just recently published in an internal peer-review journal providing credibility to the data. InMed is not just focusing on rare cannabinoid research but also investing time and resources into its manufacturing process. So far, this process allows for cannabinoid synthesis to create compounds in the laboratory that are bioidentical to those derived from the cannabis plant. In addition, this move recognizes the limited availability of rare cannabinoids, making it economically impractical to extract directly from the plants for pharmaceutical use. Rare cannabinoids are already being recognized for their versatility in application and how effective they are at what they do. Rare cannabinoids have the ability to deliver differentiated products, including augmenting existing CBD-based products, to consumers in the health and wellness marketplace. With companies such as InMed at the forefront of rare cannabinoid research, specifically in the pharmaceutical industry, they are shedding light on the potential of such products. They are also laying the groundwork for tapping into a sector that is expected to grow in value significantly over the next few years. Most importantly, these companies, InMed specifically, are positioning themselves to reap big from the inevitable boom that will define the sector. For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• Bitcoin is becoming increasingly popular, having already been adopted as legal tender by El Salvador in 2021, and being bartered for incentives in other areas, such as Rio offering a 10% discount when taxes are paid in Bitcoin
• Instead of spending, some crypto owners (HODLers) are holding crypto in high-yield savings accounts, collecting up to 12% APY interest – benefiting despite the volatility of the coin
• LQwD has seen exponential growth since its completed acquisition in June 2021, with a current Bitcoin holding of almost 150 tokens
• Lightning Network has also grown significantly over the past year in terms of number of nodes, Bitcoin capacity and payment channels

Since the beginning of 2020, Bitcoin has appreciated in value by over 700%, helping hedge against inflation. While fiat currencies are printing more and more money to keep up with spending, Bitcoin is limited to 21 million BTC. Even with Bitcoin having a high value, it is possible to purchase partial amounts of the coin, as it is divisible by 1 million. Although considered rather volatile, Bitcoin is one currency that (in the long-term) could stand up against the inflation rates created by the mass production of other fiat currencies, like euros and the U.S. dollar (https://ibn.fm/yhrTb). With the volatility of Bitcoin in question, some people who have purchased the coin have decided to do nothing with it except hold it. These people have been given the name HODLers, meaning they hold crypto, often choosing to use a high-yield savings account. These accounts have almost a negligible bank deposit interest rate (0.5%), but the high-yield crypto savings accounts produce interest rates of up to 12% annual percentage yield (“APY”). Even so, Bitcoin is growing in popularity, with more countries worldwide considering the use of cryptocurrency as legal tender. In 2021, El Salvador was the first to implement Bitcoin as legal tender across the country. Even the U.S. administration made it clear that it would not ban cryptocurrency. Some states or townships have openly embraced Bitcoin, such as the city of Rio that is offering taxpayers a 10% discount when paying their taxes with the cryptocurrency. Uniquely positioned to further drive Bitcoin adoption is LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech company that has focused on creating enterprise-grade infrastructure for Bitcoin adoption, making it easier to complete transactions with the crypto coin on the Lightning Network. The Lightning Network is a second-layer protocol that sits above the bitcoin blockchain. LQwD’s proprietary platform as a service (“PaaS”), which leverages Lighting Network technology, was introduced to the public on November 17, 2021, and offers users lower transaction fees and faster transaction settlement times. Formerly known as Interlapse Technologies Corp., LQwD’s acquisition was completed in June 2021 and since then, the company has seen exceptional growth – a trend expected to continue into 2022. The company grew alongside the Lightning Network, which also achieved several major milestones since January 2021: node growth of 105% for node establishment from 770 to over 15,000, increased Bitcoin capacity from 1,125 BTC to almost 3,000 BTC – up 160% to September 30, 2021, and a 92% increase in the number of payment channels, totaling more than 73,000 up from the initial 38,000. “The remarkable growth of the Lightning Network has validated LQwD’s reason to be hyper-focused on Lightning, and I look forward to continuing to expand our business on this rapidly growing global payment network,” LQwD CEO Shone Anstey said (https://ibn.fm/bC3NA). The company’s highlights for the last six months of 2021 include:

• A non-brokered private placement with proceeds of CAN $5 million in June 2021
• An offering of 23 million units which produced proceeds of C$8,050,000 (US$6.4 million) at the end of October 2021
• The cumulative acquisition of 150 Bitcoin as an operating asset for the company

LQwD plans to continue leveraging its position as a public company, enhancing trust in its products and services, and leveraging its shares to attract and retain top industry talent – bringing vast opportunities and marketing segments for digital payments and financial services at a global scale. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• SRAX will host their inaugural Metals & Mining Conference on January 27, 2022
• The conference will be held on Sequire’s Virtual Events platform and will play host to over 70 companies along with a series of industry experts and thought leaders
• The event marks the latest iteration of SRAX’s extensive conference series, which saw them host the flagship LD Micro Main Event in October 2021

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced that it will be hosting the inaugural Sequire Metals & Mining Conference, a one-day investor event featuring a number of prominent public mining companies and industry experts, on its Sequire Virtual Events platform on January 27, 2022 (https://ibn.fm/0uDUG). The metals and mining sector has become increasingly crucial to the proper functioning and health of the global economy. Given the robust level of interest surrounding the sector, SRAX have sought to host a full day of networking and learning featuring some of the premier innovators within the metals and mining space. The event will be hosted on the company’s proprietary Sequire platform and will feature presentations, one-on-one meetings with company executives, and a series of influential industry speakers and thought leaders. This year’s inaugural Metals & Mining Conference will feature approximately 70 companies in attendance, divided into four distinct tracks (https://ibn.fm/46WMi). Each of the companies in attendance will carry out a 25-minute presentation, thus providing them with an opportunity to share their stories and operational highlights with the thousands of conference delegates in attendance. Investors attending the virtual event will be able to meet with corporate management teams in a live, one-on-one, or small group meeting format to gain further insights as to an individual company’s operational highlights. “This has been one of the fastest growing events we have ever hosted. Its clear companies are eager to tell their story and give the latest company updates, and investors are registering to listen. We look forward to hosting everyone for our first event of 2022 and kicking off the year in a strong way,” said Morgan-Lea Fogg, Vice President of Community & Events at SRAX. Boasting a network of over nine million influential, forward-thinking investors and shareholders, the Sequire platform has established a robust reputation as a venue where investors can congregate to learn, share, and network on a wide range of industry related topics. The Sequire Metals & Mining Conference Event is the latest highlight within an extensive conference series designed by SRAX and Sequire to offer added value to their budding investor community. Sequire has previously played host to major events, such as the 2021 LD Micro Event (https://ibn.fm/MF8Lo), a prominent three-day joint in-person and virtual investor conference, which was held between October 12-14, 2021. In addition to featuring 139 small- and mid-cap companies in attendance, the event also played host to a myriad of influential keynote speakers and thought leaders. Sequire’s extensive and diverse conference series ranks amongst the various strategies employed by parent company, SRAX, to augment and streamline their operations over the past several months. Other measures undertaken by the company include naming entrepreneur and 2020 presidential candidate, Brock Pierce, to the company’s board of directors as well as divesting an equity stake in TI Health (formerly known as SRAXmd). Through its constant focus on adding value for the millions of investors on its Sequire platform, as well as for their near 200 publicly listed corporate subscribers, the Sequire platform has established a strong reputation as a venue where investors congregate to learn, share, and network on a wide range of industry related topics. The popularity and success of the upcoming Sequire Metals & Mining Conference is yet another testament to the platform’s ever-increasing prominence within the global investor community. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• CryptoHawk is designed to monitor, analyze cryptocurrencies to predict price trends and alerts traders when change occurs
• DIGIMax recently added Altcoin Radar to its CryptoHawk trading tools arsenal to detect unexpected fast rises

The world of crypto trading is known for its volatility, with wild fluctuations within the market. DigiMax Global’s (CSE: DIGI) (OTC: DBKSF) CryptoHawk, one of the world’s most powerful and complete crypto price prediction indicator tools available, can provide a bird’s eye view of crypto investing, resulting in more efficient predictions (https://ibn.fm/u5jnj). As cryptocurrencies grow in popularity, new investors entering the space will soon find out that crypto price forecasting is extremely challenging due to the market’s price volatility and dynamism. Those fast-fluctuating numbers have made millionaires of a lucky few, but delivered crushing losses to others. “Since the beginning of October, Bitcoin had been above $50,000 — for many, a sign of an ongoing bull market — but Bitcoin’s flash crash last weekend — in part because of substantial leverage trading — surprised some,” reported a recent Decrypt article, which noted that “$1.79 billion of Bitcoin was liquidated within an hour, sending its value down to around $47,000 on Friday. Bitcoin prices returned to $50,000 around noon ET on Sunday after a week of hovering in the high $40,000s.” CryptoHawk attempts to reduce some of these price forecasting challenges and is specifically designed to analyze crypto price trends and alert traders about key components that indicate the time may be right to enter the market. The innovative platform also helps traders decide whether to buy, sell, or hold the cryptocurrencies to reap the maximum benefits. It predicts crypto price trends by using deep learning algorithms, which can discover hidden patterns from data, integrate them, and create far more efficient predictions. Most recently, DigiMax added Altcoin Radar to its CryptoHawk trading tools kit (https://ibn.fm/6pU7u). “The AI-driven Altcoin Radar lists the top 100 Altcoins that meet two essential criteria,” the company announced. “[First], the coin is available on a credible cryptocurrency trading platform; and [second], the coin is monitored for attributes that give it some likelihood of a near-term significant price increase. “The top-monitored coins are listed in order of their coin momentum score,” the announcement continued. “The Altcoin Radar separates the coins into two lists. One list showcases ‘blipping’ coins on the radar that Altcoin Radar indicates as having the highest likelihood of rising in the market. The other list is continuously being monitored for changes in coin momentum. When applying and testing our new AI feature, we detected the early rise of both Shiba Inu and Dogecoin.” The Altcoin Radar addition is the third predictive tool added to DIGI’s CryptoHawk arsenal, designed to create a complete and powerful AI system that supports three different trading styles. CryptoHawk also features Long-Short Indicators, designed for day trading, which detect a price direction that is assessed on the hour for a selection of established cryptocurrencies, and Trend Watch, designed for swing trading, which provides a rolling four-day outlook for a target high and low price prediction. CryptoHawk detects when the cryptocurrency’s current price reaches its next target prediction for the investor to act on their trading strategy. “The CryptoHawk AI engine adds a considerable level of additional social media and crypto industry data,” the company noted. “By combining these data sources for Altcoin Radar, traders will gain higher confidence in our predictions. DigiMax is an artificial-intelligence-technology company committed to unlocking the potential of disruptive technologies by providing advanced financial, predictive and cryptocurrency solutions across various verticals. DigiMax is an official IBM partner, and the company’s engineering team has extensive experience in machine learning, neural language processing and AI. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

Microdose Psychedelic Insights is a cutting-edge media firm that aims to bring the psychedelics sector to the forefront of contemporary medicine by developing appealing content, disseminating financial analyses, and holding interesting industry events. On January 27, 2022, Microdose will host the Psychedelic Capital January Edition. Attendees will have access to the top firms, most recent IPOs, newest opportunities, and most in-depth market knowledge in the rapidly rising psychedelic medicine sector at the virtual event. Key Points Covered This month’s conference features dynamic presentations from Heroic Hearts Project, Entheo Digital, PurMinds NeuroPharma, HAVN Life Sciences Inc. and panel discussions on topics of Public vs Private Markets, and What Will 2022 Look Like. Heroic Hearts Project offers a proprietary program to veterans who are interested in pursuing psychedelic treatment options. Heroic Hearts Project primarily works with ayahuasca retreat centers due to the powerful effect it has shown to have on healing PTSD. The Heroic Hearts Project program has been designed to ensure veterans get the most out of this valuable opportunity and are set up for success when they return home. Entheo Digital Entheo Digital is a digital therapeutics company pursuing the creation of a wellness technology marketplace at the intersection of psychedelic therapy and experiential medicine. The company is growing the accessibility and scalability of psychedelic therapy with immersive virtual experiences. PurMinds NeuroPharma PurMinds NeuroPharma is pursuing breakthrough solutions for devastating neurological disorders with a special emphasis on neurodegenerative diseases. We strive to deliver the right drugs to the right patients by utilizing technology and championing next generation drug development approaches. Drug development for neurological disorders has been marred with failure due to imperfect modelling of human diseases in pre-clinical studies and inadequate stratification within patient recruitment for clinical trials. We use multi-omics analyses of diseased and healthy Human iPSC-derived neurons to better understand the pathophysiology of neurodegenerative diseases, which enables us to design personalized, precision neurotherapeutics. HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, HAVN Life offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Explore the Schedule *All times are Eastern Standard Time Zone. 1:30pm: Introduction Featuring Patrick Moher and Richard Skaife. 1:45pm: Doing Good Presentation – Heroic Hearts Project Featuring Jesse Gould. 2:05pm: Entheo Digital Featuring Robin Arnott, and Sandeep Prakash. 2:40pm: Public vs Private Markets Featuring Richard Skaife, Bill O’Hara, and Matthew King. 3:15pm: PurMinds NeuroPharma Featuring Susan Chapelle, and Janet Qi. 3:50pm: What Will 2022 Look Like Featuring Cody Shandraw, Sara Brittany Somerset, Tesla La Touche, Doug Drysdale. 04:25pm: HAVN Life Sciences Featuring Tim Moore. Additional information about the Psychedelic Capital: January 2022 Conference, as well as details for registration, can be found on the Psychedelic Capital conference website at the following link: https://microdose.buzz/pressrelease Why You Should Attend Attendees will be able to form contacts, network with professionals from throughout the psychedelics industry, and learn about intriguing and breakthrough pre-IPO investment opportunities in the field at the conference. For more information regarding the Psychedelic Capital Jan 27 conference, including registration and complimentary tickets, please visit https://microdose.buzz/pressrelease.